Orion Portfolio Solutions’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.48M Sell
20,574
-288
-1% -$47.3K 0.03% 473
2024
Q4
$3.15M Buy
20,862
+1,125
+6% +$175K 0.03% 488
2024
Q3
$3.06M Buy
19,737
+3,837
+24% +$573K 0.03% 494
2024
Q2
$2.18M Sell
15,900
-560
-3% -$76.7K 0.02% 614
2024
Q1
$2.19M Sell
16,460
-3,184
-16% -$413K 0.02% 622
2023
Q4
$2.78M Sell
19,644
-1,237
-6% -$163K 0.03% 476
2023
Q3
$2.54M Sell
20,881
-692
-3% -$92.2K 0.03% 511
2023
Q2
$3.03M Buy
21,573
+13,061
+153% +$1.8M 0.03% 482
2023
Q1
$1.2M Buy
+8,512
New +$1.22M 0.01% 805
2021
Q3
Sell
-2,242
Closed -$296K 648
2021
Q2
$296K Buy
2,242
+31
+1% +$4.06K 0.01% 498
2021
Q1
$284K Buy
+2,211
New +$272K 0.01% 451
2020
Q3
Sell
-550
Closed -$63K 809
2020
Q2
$63K Buy
550
+269
+96% +$28.5K ﹤0.01% 655
2020
Q1
$23K Buy
281
+28
+11% +$2.9K ﹤0.01% 791
2019
Q4
$27K Buy
+253
New +$26.4K ﹤0.01% 696

Other funds holding DGX

Orion Portfolio Solutions's DGX Position: Q1 2025 in Review

Orion Portfolio Solutions reduced its Quest Diagnostics (DGX) stake by 1.4% in Q1 2025, selling an estimated $47.3K and leaving 20,574 shares worth $3.48M. The position accounts for 0.03% of the portfolio, ranked #473.

Orion Portfolio Solutions first reported a position in DGX in Q4 2019 and has held it in 14 quarters since. 967 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

  • Orion Portfolio Solutions held 20,574 shares of Quest Diagnostics worth $3.48M as of Q1 2025.
  • Orion Portfolio Solutions sold 288 Quest Diagnostics shares in Q1 2025, an estimated $47.3K.
  • Quest Diagnostics made up 0.03% of Orion Portfolio Solutions's portfolio in Q1 2025, its #473 holding.
  • Orion Portfolio Solutions first reported a position in Quest Diagnostics in Q4 2019 and has held it in 14 quarters since.
  • 967 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.